Belite Bio (BLTE) Retained Earnings (2021 - 2025)

Belite Bio's Retained Earnings history runs 5 years deep, the most recent figure standing at -$536000.0 for Q4 2025.

• On a quarterly basis, Retained Earnings rose 99.5% year-over-year to -$536000.0 in Q4 2025; TTM through Dec 2025 was -$536000.0, a 99.5% increase from a year earlier, with the FY2025 full-year figure at -$536000.0, up 99.5% from the prior year.
• Retained Earnings advanced to -$536000.0 in Q4 2025 per BLTE's latest filing, from -$159.9 million in the prior quarter.
• Across five years, Retained Earnings topped out at -$196000.0 in Q4 2021 and bottomed at -$159.9 million in Q3 2025.
• The 5-year median for Retained Earnings is -$55.7 million (2022), against an average of -$63.3 million.
• Across the five-year window, Retained Earnings tumbled 20242.35% in 2022 and soared 99.5% in 2025, its largest moves.
• Year by year, Retained Earnings stood at -$196000.0 in 2021, then tumbled by 20242.35% to -$39.9 million in 2022, then sank by 79.34% to -$71.5 million in 2023, then slumped by 50.55% to -$107.6 million in 2024, then surged by 99.5% to -$536000.0 in 2025.
• Per Business Quant, the three latest BLTE Retained Earnings figures stand at -$536000.0 (Q4 2025), -$159.9 million (Q3 2025), and -$107.6 million (Q4 2024).